Arizona officials will announce on Wednesday the arrival of the next new thing from Google: a facility housing some of their operations to be located in the Phoenix area.  |


Macquarie Research Equities (MRE) has predicted the upcoming full year results of ANZ Bank, its preferred banking pick, will deliver solid earnings  |
The Chicago Bears and Brad Maynard have come to terms on a five-year contract extension that will keep the punter with the team through the 2010 season.  |
Patients taking high doses of cholesterol-lowering drugs need not worry that their LDL will drop too low, researchers say.  |


Black women with breast cancer have shorter survival spans than white women, and this may be related to other medical conditions, a new study suggests.  |
Treatment with a new monoclonal antibody that targets immune system B cells has shown considerable promise for treating leukemias.  |
ASCII Back To Groove with Wilo y Capone  |
Apple on Tuesday reported yet another record quarter for the company, finishing the best year in its history. The devil is in the details, however, and iPod sales were relatively flat compared with last quarter only increasing five percent. Macintosh  |
As promised, Microsoft on Tuesday issued nine separate security patches, fixing vulnerabilities in DirectX, Exchange, Internet Explorer, and Windows itself. Three of the fixes were deemed "critical," four "important," and two "moderate."  |
Arena Pharmaceuticals has announced that it was issued US patent number 6,953,787, entitled "5-HT2C Receptor Modulators," by the United States Patent and Trademark Office.  |
The company last Friday filed suit against Digene Corp., seeking a court ruling supporting Third Wave's right to sell its human papilloma virus (HPV) products. Third Wave today also filed suit against Chiron Corp., Bayer Corp., and Bayer HealthCare LLC  |
Myriad Genetics announced today that it is rapidly nearing completion of the preclinical data package on MPC-0920, its antithrombin drug candidate, for submission to the FDA prior to beginning human clinical trials.  |
Nanogen announced today its subsidiary, Epoch Biosciences, was issued Patent No. 6,951,930, "Hybridization-Triggered Fluorescent Detection of Nucleic Acids" by the U.S. Patent and Trademark Office.  |
Nabi Biopharmaceuticals has announced that it has been granted U.S. Patent No. 6,936,258 entitled "Staphylococcus Antigen and Vaccine" by the U.S. Patent and Trademark Office for the composition of a strategically important glycoprotein-based antigen (GP-1) associated with three Staphylococcal strains:  |
A Michigan State University researcher and his colleagues have shown that playing violent video games leads to brain activity pattern that may be characteristic for aggressive thoughts.  |
A Syracuse University chemistry professor has patented a device that aims to make painful fingerstick testing of glucose levels a thing of the past for diabetics.  |
Dietary supplements containing vanadium are used by body builders to help beef up muscles and by some diabetic people to control blood sugar. New research now suggests the naturally occurring but easily toxic element may help prepare the body to  |
according to new research from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). At the same time, dramatic racial disparities persist.  |
For the first time, stem cell researchers at the University of Minnesota have coaxed human embryonic stem cells to create cancer-killing cells in the laboratory, paving the way for future treatments for various types of cancers (or tumors).  |
The total cholesterol level among older adults has declined significantly, while there has been little change among younger adults, according to a study in the October 12 issue of JAMA: The Journal of the American Medical Association.  |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 ... 324 » |
 |
|